Estepan Ian Michael
Chief Operating Officer
Estepan Ian Michael has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Estepan Ian Michael is listed as Chief Operating Officer at Sarepta Therapeutics, Inc. Inside the rolling window, Estepan Ian Michael reported no open-market purchases and 1 open-market sale totaling $294K in SRPT.
Companies traded
Other insiders at SRPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$294K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Estepan Ian Michael made?
Estepan Ian Michael has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.
Which companies does Estepan Ian Michael trade?
Estepan Ian Michael has filed SEC Form 4 disclosures for 1 company, including SRPT.
When was Estepan Ian Michael's most recent SEC Form 4 filing?
Estepan Ian Michael's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Estepan Ian Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Estepan Ian Michael is listed as Chief Operating Officer.
What is Estepan Ian Michael's total buy and sell value in the current window?
Inside the rolling retention window, Estepan Ian Michael bought $0 and sold $294K based on SEC Form 4 filings.
What was Estepan Ian Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 13,187 SRPT shares on 2025-12-16, worth $294K, per SEC Form 4 filings.